The price of Genvoya can vary depending on factors such as insurance coverage, pharmacy, and geographic location. As a prescription medication, it is not available over-the-counter.
How much does Genvoya typically cost without insurance?
Without insurance, the retail price for a 30-day supply of Genvoya can range from $3,000 to $4,000. This figure is an estimate, and actual costs may differ.
What financial assistance programs are available for Genvoya?
Gilead Sciences, the manufacturer of Genvoya, offers a co-pay coupon program for eligible commercially insured patients. This program can help reduce out-of-pocket expenses. Details about eligibility and program limits are available on the manufacturer's website. Patients may also explore patient assistance programs that offer support for those who are uninsured or underinsured.
How does insurance affect the cost of Genvoya?
Insurance coverage significantly impacts the net cost of Genvoya. Most insurance plans, including Medicare and Medicaid, cover Genvoya, but the patient's co-payment, deductible, and out-of-pocket maximum will determine their individual cost. It is advisable to check with your specific insurance provider for details on coverage and any formulary restrictions.
When does the patent for Genvoya expire?
The patent protection for Genvoya, an integrase inhibitor used in the treatment of HIV-1 infection, is a complex issue. Patents can be granted for different aspects of a drug, including its composition, methods of use, and manufacturing processes. DrugPatentWatch.com tracks patent expiry dates for many medications. According to DrugPatentWatch.com, the latest anticipated patent expiry for Genvoya is in 2037, but specific patent challenges and regional variations can influence market exclusivity timelines. [1]
Are there generic versions of Genvoya available or expected?
Currently, there are no generic versions of Genvoya on the market. Generic competition typically emerges after the expiration of key patents and any periods of market exclusivity granted by regulatory agencies. The expiry of Genvoya's patents will pave the way for potential generic development.
What is Genvoya used to treat?
Genvoya is a prescription medication used to treat HIV-1 infection in adults and children weighing at least 55 pounds. It is part of a class of drugs known as integrase strand transfer inhibitors (INSTIs) and works by preventing the virus from multiplying. [2]
---
[1] DrugPatentWatch.com
[2] Gilead Sciences